AllCells Blog Creating a Robust Donor Ecosystem to Accelerate Patient Access to Cell and Gene Therapies

The possibility of allogeneic "off-the-shelf" engineered T cell therapies as an alternative to overcome the limitations of autologous therapies has long been a goal for the industry, with some of [...]The post Creating a Robust Donor Ecosystem to Accelerate Patient Access to Cell and Gene Therapies appeared first on AllCells.